Comparative anti-inflammatory effects of roxithromycin, azithromycin and clarithromycin

Journal of Antimicrobial Chemotherapy

Volumn 41, Issue SUPPL. B, 1998, Pages 47-50

  Scaglione, F ^a   Rossoni, G ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; AZITHROMYCIN; CARRAGEENAN; CLARITHROMYCIN; CYTOKINE; ERYTHROMYCIN; MACROLIDE; NIMESULIDE; ROXITHROMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG MECHANISM; INFLAMMATION; NEUTROPHIL; NONHUMAN; ORAL DRUG ADMINISTRATION; PAW EDEMA; PHAGOCYTE; RAT; RESPIRATORY BURST;

EID: 0031923568     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/41.suppl_2.47     Document Type: Article

References (27)

1. Itkin, I. H. & Menzel, M. L. (1970). The use of macrolide antibiotic substances in the treatment of asthma. Journal of Allergy 45, 146-62.
2. Spector, S. L., Katz, F. H. & Farr, R. S. (1974). Troleandomycin: effectiveness in steroid-dependent asthma and bronchitis. Journal of Allergy and Clinical Immunology 54, 367-79.
3. Miyatake, H., Suzuki, K., Taki, F., Takagi. K. & Satake, T. (1991). Effect of erythromycin on bronchial hyperresponsiveness in patients with bronchial asthma. Arzneimittel Forschung 41, 552-6.
4. Miyatake, H., Taki, F., Taniguchi, H., Suzuki, R., Takagi, K. & Satake, T. (1991). Erythromycin reduces the severity of bronchial hyperresponsiveness in asthma. Chest 99, 670-3.
5. Kadota, J., Sakito, O., Kohno, S., Abe, K., Shirai, R., Kawakami, K. et al. (1994). Roxithromycin treatment in patients with chronic lower respiratory tract disease - its clinical efficacy and effect on cytokine. (In Japanese) Kansenshogaku Zasshi (Journal of the Japanese Association for Infectious Diseases) 68, 27-33.
6. Shirai, T., Sato, A. & Chida, K. (1995). Effect of 14-membered ring macrolide therapy on chronic respiratory tract infections and polymorphonuclear leukocyte activity. Internal Medicine 34, 469-74.
7. Eady, E. A., Holland, K. T. & Cunliffe, W. J. (1982). The use of antibiotics in acne therapy: oral or topical administration? Journal of Antimicrobial Chemotherapy 10, 89-115.
8. Scholtz, J. R. (1977). Management of acne vulgaris. Rational Drug Therapy 11, 1-6.
9. Dalziel, K., Dykes, P. J. & Marks, R. (1987). The effect of tetracycline and erythromycin in a model of acne-type inflammation. British Journal of Experimental Pathology 68, 67-70.
10. Tarayre, J. P., Aliaga, M., Barbara, M., Villanova, G., Ballester, R., Tisne-Versailles, J. et al. (1987). Cutaneously applied erythromycin base reduces various types of inflammatory reactions in mouse ear. International Journal of Tissue Reactions 9, 77-85.
11. Plewig, G. & Schopf, E. (1975). Anti-inflammatory effects of antimicrobial agents: an in vivo study. Journal of Investigative Dermatology 65, 532-6.
12. Kita, E., Sawaki, M., Mikasa, K., Hamada, K., Takeuchi S., Maeda, K. et al. (1993). Alterations of host response by a long-term treatment of roxithromycin. Journal of Antimicrobial Chemotherapy 32, 285-94.
13. Konno, S., Adachi, M., Asano, K., Okamoto, K. & Takahashi, T. (1993). Anti-allergic activity of roxithromycin: inhibition of interleukin-5 production from mouse T lymphocytes. Life Sciences 52, PL25-30.
14. Konno, S., Asano, K., Kurukawa, M., Ikeda, K., Okamoto, K. & Adachi, M. (1994). Antiasthmatic activity of a macrolide antibiotic, roxithromycin: analysis of possible mechanisms in vitro and in vivo. International Archives of Allergy and Immunology 105, 308-16.
15. Agen, C., Danesi, R., Blandizzi, C., Costa, M., Stacchini, B., Favini, P. et al. (1993). Macrolide antibiotics as anti-inflammatory agents: roxithromycin in an unexpected role. Agents and Actions 38, 85-90.
16. Nilsen, O. G. (1995). Pharmacokinetics of macrolides. Comparison of plasma, tissue and free concentrations with special reference to roxithromycin. Infection 23, Suppl. 1, S5-9.
17. Carbon, C. (1995). Clinical relevence of intracellular and extracellular concentrations of macrolides. Infection 23, Suppl. 1, S10-14.
18. Van Arman, C. G., Begany, A. J., Miller, L. M. & Pless, H. H. (1965). Some details of the inflammations caused by yeast and carrageenin (with appendix on the kinetics of the reaction). Journal of Pharmacological and Experimental Therapy 150, 328-34.
19. Tamaoki, J., Sakai, N., Tagaya, E. & Konno, K. (1994). Macrolide antibiotics protect against endotoxin-induced vascular leakage and neutrophil accumulation in rat trachea. Antimicrobial Agents and Chemotherapy 38, 1641-3.
20. Esterly, N. B., Furey, N. L. & Flanagan, L. E. (1978). The effect of antimicrobial agents on leukocyte chemotaxis. Journal of Investigative Dermatology 70, 51-5.
21. Labro, M. T., el Benna, J. & Babin-Chevaye, C. (1989). Comparison of the in-vitro effects of several macrolides on the oxidative burst of human neutrophils. Journal of Antimicrobial Chemotherapy 24, 561-72.
22. Hand, W. L., Hand, D. L. & King-Thompson, N. L. (1990) Antibiotic inhibition of the respiratory burst response in human polymorphonuclear leukocytes. Antimicrobial Agents and Chemotherapy 34, 863-70.
23. Aoshiba, K., Nagai A. & Konno, K. (1995). Erythromycin shortens neutrophil survival by accelerating apoptosis. Antimicrobial Agents and Chemotherapy 39, 872-7.
24. Yoshimura, T., Kurita, C., Yamazaki, K., Shindo, J., Morishima, I., Machida, K. et al. (1995). Effects of roxithromycin on proliferation of peripheral blood mononuclear cells and production of lipopolysaccharide-induced cytokines. Biological and Pharmaceutical Bulletin 18, 876-81.
25. Brand, L. M., Skare, K. L., Loomans, M. E., Reller, H. H., Schwen, R. J., Lade, D. A. et al. (1990). Anti-inflammatory pharmacology and mechanism of the orally active capsaicin analogs, NE-19550 and NE-28345. Agents and Actions 31, 329-40.
26. Kumakura, S., Mishima, M., Kobayashi, S., Shirota, H., Abe, S., Yamada, K. et al. (1990). Inhibitory effect of indomethacin farnesil, a novel anti-inflammatory prodrug, on carrageenin-induced inflammation in rats. Agents and Actions 29, 286-91.
27. Blackham, A., Norris, A. A. & Woods, F. A. (1985). Models for evaluating the anti-inflammatory effects of inhibitors of arachidonic acid metabolism. Journal of Pharmacy and Pharmacology 37, 787-93.